|
|
|
40
|
50023
|
OROFER 10MG/ML SYR (EMC/COL) IRON 3 HYDROXY P
|
IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
150ML
|
A
|
10.87
|
0.07
|
SYRUP
|
150
|
ML
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
50023
|
OROFER 10MG/ML SYR (EMC) IRON 3 HYDROXY
|
IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
150ML
|
A
|
12.5
|
0.0834
|
ML
|
150
|
BOTT
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
42
|
50023
|
OROFER 10MG/ML SYR (EMC) IRON 3 HYDROXY
|
IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
150ML
|
A
|
12.50
|
0.08
|
ML
|
150
|
BOTT
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
200404
|
IRON PREPARATIONS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
40
|
50031
|
FERRUM 50MG/ML DROPS (VFI/AHI) IRON 3 HYDROXY
|
IRON 3 HYDROXY POLYMALTOSE
|
FERRUM
|
30ML
|
C
|
33.98
|
33.98
|
DROPS
|
0
|
BOTT
|
VFI
|
VIFOR (INTERNATIONAL) INC,
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
50033
|
COMPIRON PAEDIATRIC 50MG/ML DROPS (INC) IRON 3 HYDROXY POLYM
|
IRON 3 HYDROXY POLYMALTOSE
|
COMPIRON PAEDIATRIC
|
30ML
|
C
|
14.1897
|
14.1897
|
BOTT
|
30
|
BOTT
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
200404
|
IRON PREPARATIONS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
42
|
50033
|
COMPIRON PAEDIATRIC 50MG/ML DROPS (C)
|
IRON 3 HYDROXY POLYMALTOSE
|
COMPIRON PAEDIATRIC
|
30ML
|
C
|
11.20
|
11.20
|
BOTT
|
30
|
BOTT
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
200404
|
IRON PREPARATIONS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
40
|
5011H
|
AAP-FLUNARIZINE 5MG CAP (APO/COL)
|
FLUNARIZINE
|
AAP-FLUNARIZINE
|
100'S
|
A
|
14.33
|
0.14
|
CAPSULE
|
180
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
283292
|
ANTIMIGRAINE AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
5011J
|
APO-FLUNARIZINE 5MG TAB (APO)
|
FLUNARIZINE
|
AAP-FLUNARIZINE
|
100'S
|
A
|
14.62
|
0.1462
|
TAB
|
180
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283292
|
ANTIMIGRAINE AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMIGRAINE AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
5011K
|
FLULINE 5MG TAB (JLP) FLUNARIZINE
|
FLUNARIZINE
|
FLULINE
|
20X10
|
A
|
12.78
|
0.06
|
TAB
|
180
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283292
|
ANTIMIGRAINE AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
ANTIMIGRAINE AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
50411
|
ELOXATIN 50MG SOLN (SFA/COL) OXALIPLATIN
|
OXALIPLATIN
|
ELOXATIN
|
50MG VIAL
|
BQ
|
67.96
|
67.96
|
SOLUTION
|
0
|
VIAL
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
50411
|
ELOXATIN 50MG INJ SOLN (SFA) OXALIPLATIN (BQ)
|
OXALIPLATIN
|
ELOXATIN
|
50MG VIAL
|
BQ
|
182.13
|
182.1277
|
VIAL
|
0
|
VIAL
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
5041P
|
OXALIPLATIN 50MG SOLN FOR INJ (FSB/ATB)
|
OXALIPLATIN
|
OXALIPLATIN
|
50MG VIAL
|
BQ
|
38.06
|
38.06
|
SOLUTION FOR
|
0
|
VIAL
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
5041V
|
OXALITHER 50MG SOLN FOR INJ (TPP/AHI) OXALIPLATIN
|
OXALIPLATIN
|
OXALITHER
|
50MG VIAL
|
BQ
|
46.18
|
46.18
|
SOLUTION FOR
|
0
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
5041V
|
OXALITHER 50MG SOLN FOR INJ (TPP) OXALIPLATIN
|
OXALIPLATIN
|
OXALITHER
|
50MG VIAL
|
BQ
|
38.36
|
38.36
|
VIAL
|
0
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
50421
|
ELOXATIN 100MG SOLN FOR INJ (SFA/COL) OXALIPLATIN
|
OXALIPLATIN
|
ELOXATIN
|
20ML
|
B
|
135.92
|
135.92
|
SOLUTION FOR
|
0
|
VIAL
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
50421
|
ELOXATIN 5MG/ML INJ SOLN (SFA) OXALIPLATIN (C)
|
OXALIPLATIN
|
ELOXATIN
|
20ML
|
C
|
326.2
|
326.1989
|
VIAL
|
0
|
VIAL
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
50421
|
ELOXATIN 5MG/ML INJ SOLN (SFA) OXALIPLATIN
|
OXALIPLATIN
|
ELOXATIN
|
20ML
|
BQ
|
386.00
|
386.00
|
VIAL
|
0
|
VIAL
|
SFA
|
SANOFI
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
5042AB
|
OXALIPLATIN 5MG/ML INJ SOLN (CHC) (BQ)
|
OXALIPLATIN
|
OXALIPLATIN
|
20ML
|
BQ
|
49.2
|
49.2017
|
VIAL
|
0
|
VIAL
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
5042Z
|
OXALITHER 5MG/ML SOLN FOR INJ (TPP) OXALIPLATIN
|
OXALIPLATIN
|
OXALITHER
|
20ML
|
BQ
|
94.98
|
94.98
|
VIAL
|
0
|
VIAL
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
50431
|
OXALIPLATIN 5MG/ML INJ SOLN (KWA)
|
OXALIPLATIN
|
OXALIPLATIN
|
40ML
|
BQ
|
124.7711
|
124.7711
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
